Publication | Closed Access

Use of rituximab and irradiated donor-derived lymphocytes to control Epstein–Barr virus-associated lymphoproliferation in patients undergoing related haplo-identical stem cell transplantation

Cell TherapyTransplantationMarrow TransplantationStem Cell TransplantationImmunologyHematologyEpstein–barr Virus-associated LymphoproliferationIrradiated Donor-derived LymphocytesImmunotherapyMedicineCell TransplantationGraft Rejection